| Literature DB >> 30861992 |
Bihui Liu1,2,3,4, Jing Zhang5, Ruokun Yi6,7,8, Xianrong Zhou9,10, Xingyao Long11,12, Yanni Pan13,14, Xin Zhao15,16,17.
Abstract
Lactobacillus fermentum CQPC08 (LF-CQPC08) is a newly discovered strain of bacteria isolated and identified from traditional pickled vegetables in Sichuan, China. We used 4-nitroquinoline 1-oxide to establish an experimental tongue cancer mouse model to evaluate the preventive effect of LF-CQPC08 on tongue cancer in vivo. Lactobacillus delbruechii subsp. bulgaricus, is a common commercial strain and is used as a positive control to compare the effect with LF-CQPC08. The preventive strength and mechanism of LF-CQPC08 on tongue cancer were determined by measuring the biochemical indicators in mouse serum and tissues. Our results showed LF-CQPC08 inhibits the decline of splenic index, thymus index, percentage of phagocytic macrophages, and phagocytic index effectively. LF-CQPC08 also increased levels of mouse serum granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-CSF (GM-CSF), immunoglobulin (Ig)G, IgM levels of serum interleukin (IL)-4, IL-12, tumor necrosis factor-alpha, and interferon-gamma levels, thereby inhibiting the decline in immunity caused by tongue cancer. It also increased the activity levels of superoxide dismutase and glutathione peroxidase and decreased the levels of malondialdehyde in the tissues of the tongue cancer mouse model, thereby suppressing the oxidative stress damage in the tissue caused by tongue cancer. Through quantitative PCR, LF-CQPC08 upregulated the mRNA expression of nuclear factor-erythroid 2 related factor 2 (Nrf2), heme oxygenase-1 (HO-1), glutathione-S-transferases-π (GST-π), and Bcl-2-associated X protein (Bax), and downregulated the mRNA expression of p53, p63, p73, phosphatase and tensin homolog (PTEN), B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-xL) in the tongue tissues of the tongue cancer mouse. These results indicated that LF-CQPC08 reduced the influence of tongue cancer on the immune system and oxidative balance and improved the immunity and enhanced antioxidant capacity of the mouse model, thereby preventing tongue cancer. LF-CQPC08 could be used as a microbial resource with a preventive effect on tongue cancer.Entities:
Keywords: 4-nitroquineline-1-oxide; C57BL/6 mice; Lactobacillus fermentum CQPC08; protein; tongue cancer
Year: 2019 PMID: 30861992 PMCID: PMC6463013 DOI: 10.3390/foods8030093
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Sequences of primers used in this study.
| Gene Name | Sequence |
|---|---|
| p53 | Forward: 5′-TAACAGTTCCTGCATGGGCGGC-3′ |
| Reverse: 5′-AGGACAGGCACAAACACGCACC-3′ | |
| p63 | Forward: 5′-GTCAGCCACCTGGACGTATT-3′ |
| Reverse: 5′-ACCTGTGGTGGCTCATAAGG-3′ | |
| p73 | Forward: 5′-GAGCCTTTGGTTGACTCCT-3′ |
| Reverse: 5′-CCACCGTGTACCTTGTTCAT-3′ | |
| PTEN | Forward: 5′-TGGAAAGGGACGAACTGGTG-3′ |
| Reverse: 5′-CATAGCGCCTCTGACTGGGA-3′ | |
| Nrf2 | Forward: 5′-CAGTGCTCCTATGCGTGAA-3′ |
| Reverse: 5′-GCGGCTTGAATGTTTGTC-3′ | |
| HO-1 | Forward: 5′-ACAGATGGCGTCACTTCG-3′ |
| Reverse: 5′-TGAGGACCCACTGGAGGA-3′ | |
| GST-π | Forward: 5′-CTCTGTCTACGCAGCACTGAATC-3′ |
| Reverse: 5′-CAAGCCTTGCATCCAGGTATC-3′ | |
| Bax | Forward: 5′-TTGCTACAGGGTTTCATC-3′ |
| Reverse: 5′-TCCAGTTCATCTCCAATTC-3′ | |
| Bcl-2 | Forward: 5′-GAGATCGTGATGAAGTACATAC-3′ |
| Reverse: 5′-TCAGGCTGGAAGGAGAAG-3′ | |
| Bcl-xL | Forward: 5′-CTTTCGGGATGGAGTAAAC-3′ |
| Reverse: 5′-AGGTGGTCATTCAGATAGG-3′ | |
| GAPDH | Forward: 5′-AGGTCGGTGTGAACGGATTTG-3′ |
| Reverse: 5′-GGGGTCGTTGATGGCAACA-3′ |
PTEN: phosphatase and tensin homolog; Nrf2: nuclear factor-erythroid 2 related factor 2; HO-1: heme oxygenase-1; GST-π: glutathione-S-transferases-π; Bax: Bcl-2-associated X protein; Bcl-2: B-cell lymphoma 2; Bcl-xL: B-cell lymphoma-extra large; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.
Figure 1Body weight of mice during the experiment. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg).
Effect of Lactobacillus fermentum CQPC08 on immune organ index in mice with tongue cancer.
| Group | Spleen Index | Thymus Index |
|---|---|---|
| Normal | 5.33 ± 0.31 a | 2.52 ± 0.15 a |
| Control | 2.69 ± 0.28 d | 1.36 ± 0.10 c |
| LDSB | 3.58 ± 0.21 c | 1.79 ± 0.09 b |
| LF-CQPC08-L | 3.67 ± 0.33 c | 1.85 ± 0.13 b |
| LF-CQPC08-H | 4.69 ± 0.24 b | 1.93 ± 0.11 b |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg).
Effect of Lactobacillus fermentum CQPC08 on phagocytosis of macrophages in mice with tongue cancer.
| Group | Phagocytic Percentage (%) | Phagocytic Index |
|---|---|---|
| Normal | 37.62 ± 2.55 a | 1.71 ± 0.18 a |
| Control | 16.31 ± 2.03 d | 0.56 ± 0.07 d |
| LDSB | 22.17 ± 2.19 c | 0.94 ± 0.08 c |
| LF-CQPC08-L | 23.02 ± 2.67 c | 0.98 ± 0.11 c |
| LF-CQPC08-H | 30.12 ± 1.74 b | 1.39 ± 0.12 b |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg).
Serum levels of G-CSF, GM-CSF, IgG and IgM in mice.
| Group | G-CSF (pg/mL) | GM-CSF (pg/mL) | IgG (μg/mL) | IgM (μg/mL) |
|---|---|---|---|---|
| Normal | 557.28 ± 21.05 a | 25.87 ± 1.03 a | 536.79 ± 15.62 a | 5.87 ± 0.25 a |
| Control | 218.67 ± 14.32 d | 14.32 ± 0.49 d | 234.15 ± 12.17 d | 2.61 ± 0.13 d |
| LDSB | 341.28 ± 18.97 c | 18.43 ± 0.51 c | 368.36 ± 13.25 c | 3.77 ± 0.21 c |
| LF-CQPC08-L | 352.17 ± 22.08 c | 18.89 ± 0.44 c | 377.21 ± 16.23 c | 3.89 ± 0.23 c |
| LF-CQPC08-H | 435.64 ± 24.52 b | 22.08 ± 0.36 b | 450.22 ± 15.20 b | 4.97 ± 0.18 b |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg). G-CSF: granulocyte-colony stimulating factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; IgG: immunoglobulin G; IgM: immunoglobulin M.
Serum cytokines levels of IL-4, IL-12, TNF-α and IFN-γ in mice.
| Group | IL-4 (pg/mL) | IL-12 (pg/mL) | TNF-α (pg/mL) | IFN-γ (pg/mL) |
|---|---|---|---|---|
| Normal | 67.32 ± 2.56 e | 733.25 ± 22.59 a | 163.58 ± 10.11 a | 155.12 ± 11.05 a |
| Control | 30.58 ± 2.29 a | 162.37 ± 12.15 d | 31.05 ± 2.32 d | 29.36 ± 4.32 d |
| LDSB | 42.12 ± 3.15 d | 255.36 ± 25.30 c | 78.20 ± 9.52 c | 55.21 ± 5.36 c |
| LF-CQPC08-L | 43.25 ± 3.08 b | 259.17 ± 31.02 c | 81.98 ± 8.35 c | 57.89 ± 8.36 c |
| LF-CQPC08-H | 55.29 ± 2.91 c | 452.84 ± 26.34 b | 118.05 ± 5.13 b | 105.28 ± 4.11 b |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg). IL-4: interleukin-4; IL-12: interleukin-12; TNF-α: tumor necrosis factor-α; IFN-γ: interferon-γ.
Tongue tissue levels of SOD, GSH-Px and MDA in mice.
| Group | SOD (U/mgprot) | GSH-Px (U/mgprot) | MDA (nmol/mgprot) |
|---|---|---|---|
| Normal | 73.52 ± 4.31 a | 123.05 ± 7.82 a | 0.88 ± 0.07 d |
| Control | 25.77 ± 2.19 d | 46.78 ± 3.54 d | 3.72 ± 0.23 a |
| LDSB | 48.37 ± 3.66 c | 74.23 ± 5.22 c | 2.25 ± 0.28 b |
| LF-CQPC08-L | 49.69 ± 4.02 c | 76.15 ± 5.31 c | 2.11 ± 0.25 b |
| LF-CQPC08-H | 60.87 ± 4.33 b | 97.82 ± 6.28 b | 1.42 ± 0.18 c |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg). SOD: superoxide dismutase; GSH-Px: glutathione peroxidase; MDA: malondialdehyde.
p53, p63, p73 and PTEN mRNA expression in tongue tissue of mice (relative to multiple of control group).
| Group | p53 | p63 | p73 | PTEN |
|---|---|---|---|---|
| Normal | 0.11 ± 0.02 d | 0.09 ± 0.03 d | 0.18 ± 0.02 d | 0.32 ± 0.03 d |
| Control | 1.00 ± 0.06 a | 1.00 ± 0.04 a | 1.00 ± 0.07 a | 1.00 ± 0.04 a |
| LDSB | 0.65 ± 0.04 b | 0.78 ± 0.04 b | 0.62 ± 0.05 b | 0.75 ± 0.03 b |
| LF-CQPC08-L | 0.63 ± 0.03 b | 0.75 ± 0.04 b | 0.59 ± 0.06 b | 0.67 ± 0.04 b |
| LF-CQPC08-H | 0.29 ± 0.03 c | 0.58 ± 0.03 c | 0.31 ± 0.05 c | 0.48 ± 0.04 c |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg).
Nrf2, HO-1, and GST-π mRNA expression in tongue tissue of mice (relative to multiple of control group).
| Group | Nrf2 | HO-1 | GST-π |
|---|---|---|---|
| Normal | 4.02 ± 0.25 a | 4.52 ± 0.15 a | 5.87 ± 0.21 a |
| Control | 1.00 ± 0.12 d | 1.00 ± 0.05 d | 1.00 ± 0.16 d |
| LDSB | 2.38 ± 0.15 c | 2.67 ± 0.18 c | 3.66 ± 0.25 c |
| LF-CQPC08-L | 2.49 ± 0.26 c | 2.81 ± 0.16 c | 3.81 ± 0.23 c |
| LF-CQPC08-H | 3.11 ± 0.15 b | 3.66 ± 0.22 b | 4.98 ± 0.29 b |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg).
Nrf2, HO-1, and GST-π mRNA expression in tongue tissue of mice (relative to multiple of control group).
| Group | Bax | Bcl-2 | Bcl-xL |
|---|---|---|---|
| Normal | 8.21 ± 0.36 a | 0.35 ± 0.03 d | 0.26 ± 0.05 d |
| Control | 1.00 ± 0.25 d | 1.00 ± 0.06 a | 1.00 ± 0.07 a |
| LDSB | 4.87 ± 0.32 c | 0.77 ± 0.05 b | 0.69 ± 0.02 b |
| LF-CQPC08-L | 5.03 ± 0.24 c | 0.72 ± 0.06 b | 0.68 ± 0.05 b |
| LF-CQPC08-H | 6.79 ± 0.39 b | 0.54 ± 0.04 c | 0.45 ± 0.04 c |
Values presented are the mean ± standard deviation (N = 10/group). a–d Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. LDSB: mice treated with 4NQO and Lactobacillus delbruechii subsp. bulgaricus (1.0 × 109 CFU/kg); LF-CQPC08-L: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 108 CFU/kg); LF-CQPC08-H: mice treated with 4NQO and Lactobacillus fermentum CQPC08 (1.0 × 109 CFU/kg).